New Study Results Indicate Superior Absorption of RLF-OD032 in Fasted State Compared to KUVAN ®, Potentially Enabling Flexible Dosing Options The patent filings follow the recently announced ...
No Notice of Opposition or Extension Request has Been Received in Relation to the Application; Certificate of Registration Expected by Late April GENEVA, SWITZERLAND / ACCESSWIRE / February 8, 2022 / ...
GENEVA, SWITZERLAND / ACCESSWIRE / October 25, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering ...
EQS-Ad-hoc: Relief Therapeutics Holding SA / Key word(s): Patent Relief Files Trademark Application for RLF-100 With the U.S. Patent and Trademark Office 08-Feb-2022 / 07:00 CET/CEST Release of an ad ...
RELIEF THERAPEUTICS Holding 2,81 USD +1,26 % Nasdaq OTC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback